| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/18/2004 | WO2004022558A2 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022554A1 Quinazolinone derivatives |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 03/18/2004 | WO2004022054A1 Pyrazolopyridines and methods of making and using the same |
| 03/18/2004 | WO2004021989A2 Imidazolopyridines and methods of making and using the same |
| 03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/18/2004 | WO2004010512A9 Heteroatom-containing diamondoid transistors |
| 03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003070731A3 Azabicyclic compounds for the treatment of disease |
| 03/18/2004 | WO2003035615A3 Tyrosine kinase inhibitors |
| 03/18/2004 | US20040054230 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040054173 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 03/18/2004 | US20040053970 Emzyme inhibitors, a 4-pyridinyl-3-pyrazoles derivatives, treating animal having cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic; a plant having yeast infection and viral infection |
| 03/18/2004 | US20040053960 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/18/2004 | US20040053959 Novel processes and intermediates for preparing triazolo-pyridines |
| 03/18/2004 | US20040053958 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053954 Treating bacterial infections with a 1,2,3,4-tetrahydrobeta-carbolin-2-yl-alkyl-1-one; chemical intermediates, amidation |
| 03/18/2004 | US20040053952 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 03/18/2004 | US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use |
| 03/18/2004 | US20040053949 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053932 Peptide deformylase inhibtors |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053930 7-Chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 03/18/2004 | US20040053929 1, 2, 5, 10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 03/18/2004 | US20040053928 Quinoline derivatives as antibacterials |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040052822 Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 03/18/2004 | DE10242941A1 New 2-(pyrazolo-(3,4-b)-pyridinyl)-5-pyridinyl-4-pyrimidinylamine derivative, is a soluble guanylate cyclase stimulant useful e.g. for treating cardiovascular diseases, hypertension or ischemia |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2497970A1 Pyrazolopyridines and methods of making and using the same |
| 03/18/2004 | CA2497968A1 Imidazolopyridines and methods of making and using the same |
| 03/18/2004 | CA2497827A1 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 03/17/2004 | EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents |
| 03/17/2004 | EP1397361A1 Carboline derivatives as pdev inhibitors |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397359A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397135A2 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways |
| 03/17/2004 | EP1397132A1 Pirenzepine ophthalmic gel |
| 03/17/2004 | EP1246816B1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/17/2004 | EP1244434B1 Use of chemotherapeutic agents |
| 03/17/2004 | EP1225174B1 Anhydrous mirtazapine crystals and process for the production thereof |
| 03/17/2004 | EP1192154B1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1140932B1 1,8-benzonaphthyridine derivatives |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 03/17/2004 | EP1047695B1 Novel bispidine antiarrhythmic compounds |
| 03/17/2004 | EP0966769B1 Novel electrode materials derived from polyquinoid ionic compounds and their uses in electrochemical generators |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483033A Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/17/2004 | CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/17/2004 | CN1483024A Vla-4 inhibitors |
| 03/17/2004 | CN1482911A A method for treating allergies using substituted pyrazoles |
| 03/17/2004 | CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706730 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors |
| 03/16/2004 | US6706728 Topical cervix immune response modifiers of imidazoquinoline amines, imidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, and thiazoloquinoline amines |
| 03/16/2004 | US6706706 Non-nucleoside reverse transcriptase inhibitors |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020584A2 Antagonists of chemokine receptors |
| 03/11/2004 | WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 03/11/2004 | WO2004020440A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/11/2004 | WO2004020439A2 Improved process for preparation of risperidone |
| 03/11/2004 | WO2004020438A2 Novel processes and intermediates for preparing triazolo-pyridines |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020373A1 Spiro compound and organic luminescence device using the same |
| 03/11/2004 | WO2004020371A1 Condensed polycyclic compound and organic light-emitting device using the same |
| 03/11/2004 | WO2004019987A1 Adhesive patch |
| 03/11/2004 | WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/11/2004 | WO2004005279A3 Substituted anthranilic amide derivatives and methods of use |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003063864A3 Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 03/11/2004 | US20040049030 Such as naphthalenes, anthracenes, phenanthrenes, tetracenes, perylenes, terrylenes, quaterrylenes, pentarylenes, hexarylenes, anthraquinones, indanthrones, and N-substituted naphthalene-1,8-dicarboxylic monoimides |
| 03/11/2004 | US20040048888 1,6-naphthyridineurea derivatives; treating excessive or undesirable angiogenesis and/or Tie2 receptor activity |
| 03/11/2004 | US20040048885 Imidazo[1,2,-A]pyridine ether compounds as ion channel modulators |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048879 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 03/11/2004 | US20040048868 Benzimidazoles |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | US20040048866 3-substituted with an oxy-, thio- or amino- group; increasing cGMP levels |
| 03/11/2004 | US20040048865 Aliphatic amino group-substituted fused ring pyrimidines or pyridines such as 2,4 dichloro-pyrido-(2,3-d)- or -(3,2d)-pyrimidines, 5,7-dichloro-(1,6) napthyridines, or 2,4-dichloro-(1,8)napthyridines |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048853 Compounds, compositions, and methods |